MHR stepped immunity recombination therapy

A therapy and step-by-step technology, applied in the field of therapy, can solve problems such as insufficient safety and effectiveness, side effects, seriousness, etc., and achieve remarkable therapeutic effect and less toxic and side effects

Inactive Publication Date: 2016-06-01
BEIJING ZHONGSHAN HOSPITAL CO LTD
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0019] However, the existing treatment methods have the following problems, for example: not safe and effective enough, and have relatively serious side effects, etc.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0030] The present invention will be specifically introduced below in conjunction with specific embodiments.

[0031] 1. Introduction of MHR ladder immunorecombination therapy

[0032] MHR ladder immune recombinant therapy, based on biology, molecular genetics, and modern immunology, according to the mainstream treatment strategy of "ladder therapy", targets the ulcer mucosa under the high-definition visualization of the latest international ultrasonic electronic gastroenteroscope. To, a few millimeters burst treatment. Scientifically aiming at the influence of many factors such as genetics, environment, gastrointestinal microorganisms, flora, and immunity on inflammatory bowel disease, using the biological effects of EGF epidermal growth factor and EGF receptor (EGFR) high affinity, using EGF epidermal cells The biological effect of growth factor and EGF receptor (EGFR) high affinity can effectively antagonize and block the biological activity of TNF-a, stimulate the mitotic...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses an MHR stepped immunity recombination therapy, comprising the following steps: orally taking 4000 ML of compound polyethylene glycol electrolyte powder the day before treatment until clear stool is present in defecation and contains little solid; subjecting a focus to fine examination, diagnosis and typing by an imported digital ultrasonic electronic gastroscopic device; targeting and focusing ulcers under acute and fine high-definition images to subject enteric cavity ulcers, erosion area and distribution to targeted spot injection repairing, and precisely repairing at ulcer mucous layers, from spot to area.The therapy of the invention is a safe and effective green therapy with no side effect.

Description

technical field [0001] The invention relates to a therapy, in particular to an MHR ladder immune recombination therapy. Background technique [0002] Inflammatory bowel disease (IBD) is a chronic non-specific intestinal inflammatory disease of unknown etiology. Includes ulcerative colitis (UC) and Crohn's disease (CD). IBD is a common disease in North America and Europe. In my country, the number of patients with this disease has been gradually increasing in the past ten years. IBD has become a common disease of the digestive system in my country. [0003] Differentiation: The main difference between Crohn's disease and ulcerative colitis is the location of the inflammation and the difference in the inflammation itself. Crohn's disease can affect any part of the digestive system, and skip lesions may occur from the mouth to the anus, mostly in the terminal ileum. Ulcerative colitis, on the other hand, is limited to the colon and rectum. Microscopically, ulcerative colit...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61M31/00A61B1/04A61B1/273A61B1/31
CPCA61M31/00A61B1/04A61B1/2736A61B1/31A61M2210/1053A61M2210/1064
Inventor 陈浩张利军叶盛白宇翔吴世玉苗勇陈和敏罗正升朱立春刘荣常健曹洪志李萌张卫武王兴涛
Owner BEIJING ZHONGSHAN HOSPITAL CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap